Cerus Corporation(CERS)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

CERS Cerus Corporation

休市中 05-15 16:00:00 EDT

2.34

-0.17

-6.77%

盘后2.32

-0.02-0.85%

19:40 EDT

最高2.51	最低2.33	成交量262.24万
今开2.49	昨收2.51	日振幅7.17%
总市值4.68亿	流通市值4.04亿	总股本2.00亿
成交额626.79万	换手率1.52%	流通股本1.73亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"CERS","market":"US","secType":"STK","nameCN":"Cerus Corporation","latestPrice":2.34,"timestamp":1778875200000,"preClose":2.51,"halted":0,"volume":2622386,"hourTrading":{"tag":"盘后","latestPrice":2.32,"preClose":2.34,"latestTime":"19:40 EDT","volume":13459,"amount":31431.5512,"timestamp":1778888440457,"change":-0.02,"changeRate":-0.008547,"amplitude":0.008547},"delay":0,"changeRate":-0.06772908366533863,"floatShares":172511680,"shares":200000000,"eps":-0.049645,"marketStatus":"休市中","change":-0.17,"latestTime":"05-15 16:00:00 EDT","open":2.49,"high":2.51,"low":2.33,"amount":6267858.6600188,"amplitude":0.071713,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.049645,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1779091200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":854686800000,"exchange":"NASDAQ","adjPreClose":2.51,"preHourTrading":{"tag":"盘前","latestPrice":2.4875,"preClose":2.51,"latestTime":"09:26 EDT","volume":10308,"amount":25496.388571199997,"timestamp":1778851607903,"change":-0.0225,"changeRate":-0.008964,"amplitude":0.023904},"postHourTrading":{"tag":"盘后","latestPrice":2.32,"preClose":2.34,"latestTime":"19:40 EDT","volume":13459,"amount":31431.5512,"timestamp":1778888440457,"change":-0.02,"changeRate":-0.008547,"amplitude":0.008547},"volumeRatio":1.200225577638757,"impliedVol":1.341,"impliedVolPercentile":0.7211},"requestUrl":"/m/hq/s/CERS/tweets","defaultTab":"tweets","newsList":[{"id":"1164242406","title":"Cerus Corporation与法国血液机构达成新型四年期血液安全系统供应协议","url":"https://stock-news.laohu8.com/highlight/detail?id=1164242406","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1164242406?lang=zh_cn&edition=full","pubTime":"2026-04-27 20:05","pubTimestamp":1777291536,"startTime":"0","endTime":"0","summary":"血液安全技术领军企业Cerus Corporation近日宣布，已与法国国家血液机构签署为期四年的创新型供应合作协议，将为其提供先进的Intercept血液病原体灭活系统。这项战略合作将显著提升法国输血医疗体系的安全标准，为当地患者提供更可靠的血液制品保障。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CERS","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616530004","title":"Cerus Corporation盘中异动 早盘快速跳水15.38%报2.14美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2616530004","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616530004?lang=zh_cn&edition=full","pubTime":"2026-03-03 22:33","pubTimestamp":1772548408,"startTime":"0","endTime":"0","summary":"北京时间2026年03月03日22时33分，Cerus Corporation股票出现异动，股价急速下跌15.38%。截至发稿，该股报2.14美元/股，成交量14.1045万股，换手率0.07%，振幅4.74%。Cerus Corporation股票所在的医疗器械行业中，整体跌幅为0.70%。Cerus Corporation公司简介：Cerus Corp是一家专注于输血安全领域的生物医药产品公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303223329a69e00b8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260303223329a69e00b8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4198","CERS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612672394","title":"Cerus Corporation盘中异动 大幅拉升5.13%报2.36美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2612672394","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2612672394?lang=zh_cn&edition=full","pubTime":"2026-02-17 23:07","pubTimestamp":1771340825,"startTime":"0","endTime":"0","summary":"北京时间2026年02月17日23时07分，Cerus Corporation股票出现波动，股价大幅上涨5.13%。截至发稿，该股报2.36美元/股，成交量17.7733万股，换手率0.09%，振幅6.25%。Cerus Corporation股票所在的医疗器械行业中，整体涨幅为1.31%。Cerus Corporation公司简介：Cerus Corp是一家专注于输血安全领域的生物医药产品公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260217230705a7048237&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260217230705a7048237&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CERS","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154802018","title":"德国巴登-符腾堡-黑森州红十字会献血服务中心启动研究，评估Cerus公司Intercept™血液系统处理病原体灭活血小板浓缩剂在常规临床实践中的应用","url":"https://stock-news.laohu8.com/highlight/detail?id=1154802018","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1154802018?lang=zh_cn&edition=full","pubTime":"2026-01-22 20:30","pubTimestamp":1769085034,"startTime":"0","endTime":"0","summary":"德国巴登-符腾堡-黑森州红十字会献血服务中心已正式启动一项研究项目，旨在评估采用Cerus公司Intercept™血液系统处理过的病原体灭活血小板浓缩剂在常规临床实践中的实际应用效果。该研究将重点关注该技术在临床环境下的安全性和有效性，为血液制品的病原体灭活处理提供重要的实践依据。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CERS","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603628029","title":"Cerus Corporation盘中异动 早盘股价大涨5.56%","url":"https://stock-news.laohu8.com/highlight/detail?id=2603628029","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603628029?lang=zh_cn&edition=full","pubTime":"2026-01-14 22:30","pubTimestamp":1768401024,"startTime":"0","endTime":"0","summary":"北京时间2026年01月14日22时30分，Cerus Corporation股票出现异动，股价急速拉升5.56%。截至发稿，该股报2.66美元/股，成交量5.8605万股，换手率0.03%，振幅5.15%。Cerus Corporation股票所在的医疗器械行业中，整体涨幅为0.00%。其相关个股中，Avita Medical, Inc.、Anteris Technologies Global Corp.、Lifeward Ltd.涨幅较大，Envue Medical, Inc.、Beyond Air, Inc.、沃氪医疗较为活跃，换手率分别为1718.02%、96.18%、3.69%，振幅较大的相关个股有Profusa, Inc.、Anteris Technologies Global Corp.、Cerus Corporation，振幅分别为7.77%、5.88%、5.47%。Cerus Corporation公司简介：Cerus Corp是一家专注于输血安全领域的生物医药产品公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114223024a4c3b149&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260114223024a4c3b149&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CERS","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140110368","title":"Cerus Corporation 2025年第四季度产品收入达5780万美元，较2024年同期增长14%","url":"https://stock-news.laohu8.com/highlight/detail?id=1140110368","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1140110368?lang=zh_cn&edition=full","pubTime":"2026-01-12 05:02","pubTimestamp":1768165346,"startTime":"0","endTime":"0","summary":"生物医药科技企业Cerus Corporation最新财报显示，公司在2025年第四季度实现产品收入5780万美元，这一数字较2024年同期的业绩表现显著提升，增幅达到14%。该增长态势凸显了公司核心产品在血液安全领域的市场渗透力持续增强。作为输血医学领域的创新领导者，Cerus Corporation专注于开发用于血液成分病原体灭活的先进技术平台。财务数据的稳健增长，为公司在2025财年的整体业绩奠定了坚实基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","CERS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112564004","title":"Cerus Corporation预计2026年全年产品收入将达2.24亿至2.28亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1112564004","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112564004?lang=zh_cn&edition=full","pubTime":"2026-01-12 05:02","pubTimestamp":1768165343,"startTime":"0","endTime":"0","summary":"血液安全技术领域的领先企业Cerus Corporation近日公布了其2026财年的业绩展望。公司预计，在血液检测与病原体灭活系统持续市场扩张的驱动下，2026年全年产品收入将达到2.24亿美元至2.28亿美元区间。\n这一预期反映了公司核心产品INTERCEPT血液系统在全球范围内，尤其是在新兴市场和应用场景中，商业化进程的稳步推进。管理层对实现这一收入目标展现出充分信心，并指出公司正通过加强生产效率和优化供应链来支持未来的增长轨迹。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CERS","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1159129168","title":"Cerus Corporation - 根据协议条款，Bca会员献血中心的Ifc持续生产将转向资源共享模式","url":"https://stock-news.laohu8.com/highlight/detail?id=1159129168","media":"美股速递","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1159129168?lang=zh_cn&edition=full","pubTime":"2025-12-11 05:21","pubTimestamp":1765401693,"startTime":"0","endTime":"0","summary":"Cerus Corporation - 根据协议条款，Bca会员献血中心的Ifc持续生产将转向资源共享模式","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CERS","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1174688027","title":"Cerus第三季度净收入为负2万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1174688027","media":"投资观察","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1174688027?lang=zh_cn&edition=full","pubTime":"2025-11-20 01:01","pubTimestamp":1763571692,"startTime":"0","endTime":"0","summary":"11月6日消息 - Cerus第三季度调整后的息税折旧摊销前利润（EBITDA）为500万美元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4198","CERS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2584350249","title":"Cerus Corporation盘中异动 早盘快速下跌5.25%报1.54美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2584350249","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2584350249?lang=zh_cn&edition=full","pubTime":"2025-11-18 00:13","pubTimestamp":1763396009,"startTime":"0","endTime":"0","summary":"北京时间2025年11月18日00时13分，Cerus Corporation股票出现波动，股价快速下挫5.25%。截至发稿，该股报1.54美元/股，成交量23.6986万股，换手率0.12%，振幅3.70%。Cerus Corporation股票所在的医疗器械行业中，整体跌幅为0.21%。其相关个股中，Autonomix Medical, Inc.、Tela Bio, Inc.、Pavmed Inc.涨幅较大，Autonomix Medical, Inc.、Surmodics, Inc.、Phaos Technology Holdings  Limited较为活跃，换手率分别为3896.24%、41.93%、11.10%，振幅较大的相关个股有Autonomix Medical, Inc.、Phaos Technology Holdings  Limited、Tela Bio, Inc.，振幅分别为59.15%、25.44%、24.01%。Cerus Corporation公司简介：Cerus Corp是一家专注于输血安全领域的生物医药产品公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118001329a4a817c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251118001329a4a817c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4198","CERS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517019963","title":"Cerus Corporation盘中异动 股价大跌5.28%报1.53美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517019963","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517019963?lang=zh_cn&edition=full","pubTime":"2025-03-07 01:51","pubTimestamp":1741283482,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日01时51分，Cerus Corporation股票出现波动，股价快速跳水5.28%。截至发稿，该股报1.53美元/股，成交量44.9979万股，换手率0.24%，振幅4.04%。Cerus Corporation股票所在的医疗器械行业中，整体跌幅为2.10%。Cerus Corporation公司简介：Cerus Corp是一家专注于输血安全领域的生物医药产品公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307015122989ed7d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307015122989ed7d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4198","CERS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2517988692","title":"Cerus Corporation盘中异动 下午盘股价大涨5.23%报1.61美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2517988692","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517988692?lang=zh_cn&edition=full","pubTime":"2025-03-05 03:20","pubTimestamp":1741116054,"startTime":"0","endTime":"0","summary":"北京时间2025年03月05日03时20分，Cerus Corporation股票出现波动，股价急速拉升5.23%。截至发稿，该股报1.61美元/股，成交量170.057万股，换手率0.92%，振幅7.19%。Cerus Corporation股票所在的医疗器械行业中，整体跌幅为0.20%。Cerus Corporation公司简介：Cerus Corp是一家专注于输血安全领域的生物医药产品公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305032055abe83f94&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250305032055abe83f94&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CERS","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2516545576","title":"Cerus Corporation盘中异动 大幅跳水5.15%报1.57美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516545576","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516545576?lang=zh_cn&edition=full","pubTime":"2025-03-04 02:10","pubTimestamp":1741025415,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日02时10分，Cerus Corporation股票出现波动，股价急速下挫5.15%。截至发稿，该股报1.57美元/股，成交量74.5206万股，换手率0.40%，振幅6.06%。Cerus Corporation股票所在的医疗器械行业中，整体涨幅为1.72%。Cerus Corporation公司简介：Cerus Corp是一家专注于输血安全领域的生物医药产品公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304021015abe6739b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250304021015abe6739b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4198","CERS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2514833375","title":"Cerus Corporation盘中异动 早盘股价大涨5.03%","url":"https://stock-news.laohu8.com/highlight/detail?id=2514833375","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514833375?lang=zh_cn&edition=full","pubTime":"2025-02-28 23:06","pubTimestamp":1740755182,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日23时06分，Cerus Corporation股票出现异动，股价急速上涨5.03%。截至发稿，该股报1.67美元/股，成交量21.3453万股，换手率0.11%，振幅4.40%。Cerus Corporation股票所在的医疗器械行业中，整体涨幅为0.07%。Cerus Corporation公司简介：Cerus Corp是一家专注于输血安全领域的生物医药产品公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228230622abe0f36c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250228230622abe0f36c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CERS","BK4198"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513756942","title":"Cerus Corporation2024财年实现净利润-20.92百万美元，同比增加44.20%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513756942","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513756942?lang=zh_cn&edition=full","pubTime":"2025-02-24 00:01","pubTimestamp":1740326473,"startTime":"0","endTime":"0","summary":"2月24日，Cerus Corporation公布财报，公告显示公司2024财年净利润为-20.92百万美元，同比增加44.20%；其中营业收入为2.01亿美元，同比增加28.85%，每股基本收益为-0.11美元。从资产负债表来看，Cerus Corporation总负债1.44亿美元，其中短期债务21.57百万美元，资产负债比为1.40，流动比率为0.03。机构评级：截至2025年2月24日，当前有5家机构对Cerus Corporation目标价做出预测，其中目标均价为3.90美元，其中最低目标价为2.50美元，最高目标价为5.00美元。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000145abd9c7ed&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250224000145abd9c7ed&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CERS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513213613","title":"坎托菲茨杰拉德公司：重申Cerus(CERS.US)评级，由增持调整至增持评级, 目标价由4.00美元调整至4.00美元。","url":"https://stock-news.laohu8.com/highlight/detail?id=2513213613","media":"金融界","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513213613?lang=zh_cn&edition=full","pubTime":"2025-02-22 01:41","pubTimestamp":1740159669,"startTime":"0","endTime":"0","summary":"坎托菲茨杰拉德公司：重申Cerus(CERS.US)评级，由增持调整至增持评级, 目标价由4.00美元调整至4.00美元。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2025/02/22014148321067.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["CERS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2513296315","title":"Cerus Corporation盘中异动 急速拉升5.17%报1.83美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2513296315","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513296315?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:31","pubTimestamp":1740148264,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时31分，Cerus Corporation股票出现波动，股价快速拉升5.17%。截至发稿，该股报1.83美元/股，成交量6.4607万股，换手率0.03%，振幅3.56%。Cerus Corporation股票所在的医疗器械行业中，整体跌幅为0.28%。Cerus Corporation公司简介：Cerus Corp是一家专注于输血安全领域的生物医药产品公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223104abd7af35&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223104abd7af35&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4198","CERS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1100945779","title":"Cerus公司2024年第四季度GAAP每股收益$(0.01)，符合预期，销售额$56.75M超出$49.64M预期","url":"https://stock-news.laohu8.com/highlight/detail?id=1100945779","media":"财报速递","labels":["express"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1100945779?lang=zh_cn&edition=full","pubTime":"2025-02-21 05:04","pubTimestamp":1740085465,"startTime":"0","endTime":"0","summary":"Cerus报告季度亏损每股$，符合分析师一致预期，与去年同期持平。公司报告季度销售额$56.75百万，高于分析师一致预期的$49.64百万，增长了14.32%。以上内容来自Benzinga Earnings专栏，原文如下：Cerus  reported quarterly losses of $ per share which met the analyst consensus estimate. This is unchanged from the same period last year.  The company reported quarterly sales of $56.75 million which beat the analyst consensus estimate of $49.64 million by 14.32 percent.  This is a 21.35 percent increase over sales of $46.77 million the same period last year.","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Cerus公司2024年第四季度GAAP每股收益$(0.01)，符合预期，销售额$56.75M超出$49.64M预期","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CERS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2512165370","title":"Cerus Corporation盘中异动 急速拉升5.41%报1.95美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512165370","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512165370?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:38","pubTimestamp":1739889502,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时38分，Cerus Corporation股票出现波动，股价急速拉升5.41%。截至发稿，该股报1.95美元/股，成交量14.5453万股，换手率0.08%，振幅3.78%。Cerus Corporation股票所在的医疗器械行业中，整体跌幅为1.30%。Cerus Corporation公司简介：Cerus Corp是一家专注于输血安全领域的生物医药产品公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223823a24aae7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223823a24aae7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4198","CERS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2511699770","title":"Cerus Corporation盘中异动 股价大涨5.28%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511699770","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511699770?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:48","pubTimestamp":1739544482,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时48分，Cerus Corporation股票出现异动，股价大幅上涨5.28%。截至发稿，该股报1.90美元/股，成交量11.7084万股，换手率0.06%，振幅5.28%。Cerus Corporation股票所在的医疗器械行业中，整体涨幅为0.06%。Cerus Corporation公司简介：Cerus Corp是一家专注于输血安全领域的生物医药产品公司。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422480298858dcc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025021422480298858dcc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["CERS","BK4198"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.cerus.com","stockEarnings":[{"period":"1week","weight":-0.1034},{"period":"1month","weight":0.1584},{"period":"3month","weight":0.0446},{"period":"6month","weight":0.4444},{"period":"1year","weight":0.814},{"period":"ytd","weight":0.1359}],"compareEarnings":[{"period":"1week","weight":0.0021},{"period":"1month","weight":0.056},{"period":"3month","weight":0.0842},{"period":"6month","weight":0.1001},{"period":"1year","weight":0.2519},{"period":"ytd","weight":0.084}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Cerus Corporation，于1991年在美国加州成立，并于1996年在特拉华州重新合并成立。该公司是一家生物医药产品公司，专注于开发和商业化INTERCEPT血液系统，以增强血液安全。公司INTERCEPT血液系统旨在与血液成分及其某些衍生物：血小板、血浆、红细胞和生产INTERCEPT纤维蛋白原复合物，或IFC，以及病原体减少的血浆、冷沉淀减少。","yearOnYearQuotes":[{"month":1,"riseRate":0.448276,"avgChangeRate":0.029715},{"month":2,"riseRate":0.4,"avgChangeRate":0.00995},{"month":3,"riseRate":0.4,"avgChangeRate":-0.018999},{"month":4,"riseRate":0.466667,"avgChangeRate":0.016249},{"month":5,"riseRate":0.533333,"avgChangeRate":-0.002563},{"month":6,"riseRate":0.551724,"avgChangeRate":0.012953},{"month":7,"riseRate":0.551724,"avgChangeRate":0.082829},{"month":8,"riseRate":0.413793,"avgChangeRate":-0.039044},{"month":9,"riseRate":0.482759,"avgChangeRate":0.013698},{"month":10,"riseRate":0.448276,"avgChangeRate":-0.027873},{"month":11,"riseRate":0.689655,"avgChangeRate":0.052842},{"month":12,"riseRate":0.482759,"avgChangeRate":0.023229}],"exchange":"NASDAQ","name":"Cerus Corporation","nameEN":"Cerus"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Cerus Corporation(CERS)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Cerus Corporation(CERS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Cerus Corporation,CERS,Cerus Corporation股票,Cerus Corporation股票老虎,Cerus Corporation股票老虎国际,Cerus Corporation行情,Cerus Corporation股票行情,Cerus Corporation股价,Cerus Corporation股市,Cerus Corporation股票价格,Cerus Corporation股票交易,Cerus Corporation股票购买,Cerus Corporation股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Cerus Corporation(CERS)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Cerus Corporation(CERS)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}